Lysophosphatidic acid effects on atherosclerosis and thrombosis. - Wikidata - wikimedia - TriplyDB

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

http://www.wikidata.org/entity/Q39608397

about

Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract Lipid phosphate phosphatase (LPP3) and vascular development Regulation of T cell motility in vitro and in vivo by LPA and LPA2 Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction.Lysophosphatidic acid induces early growth response-1 (Egr-1) protein expression via protein kinase Cδ-regulated extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) activation in vascular smooth muscle cells.Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.CRE and SRE mediate LPA-induced CCN1 transcription in mouse aortic smooth muscle cells.Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation.mTOR signaling promotes foam cell formation and inhibits foam cell egress through suppressing the SIRT1 signaling pathway

P2860

Q26829938-57BA320E-CDCE-44A5-9B66-A2BBBCA3A27F Q27002640-CB46AB8A-6753-4CA1-B44B-934086415A1E Q27320538-8F7A75AE-80D1-4418-A05D-2B81B281AFB4 Q34433358-11DC733C-461F-4341-85C6-D207C54FBF7A Q36080532-46B1B5D2-A8FD-4B55-89B7-0D6C7F5A7BD2 Q36457072-255BF798-4D09-471F-A6AF-0B297B4D0AF8 Q37608477-BFBF65C5-CE19-4712-89C1-79B936A6290C Q38680111-2888B5EC-391B-4C87-903D-FC87EEDC398A Q38981238-A33DC004-0A4C-43D7-8187-BC7665230574 Q39741685-DF92C880-740D-42C2-801F-2D7884EDD369 Q42546689-B1F9D22D-EBF6-4075-BFB7-5B5B36C00DF1

P2860

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

http://www.wikidata.org/entity/Q39608397

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

@en

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

@nl

type

label

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

@en

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

@nl

prefLabel

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

@en

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

@nl

P1433

Q39608397-EFEA749E-DF5E-4D47-B5BF-DFBDEC6E9D1D

P1476

Q39608397-B1D0F714-8E94-4B46-8B7F-105FD984C21B

P2860

Q39608397-00F88791-C049-4C8A-968A-389E3F932D3A

Q39608397-01618492-D90B-439A-A94E-30DE2D9DDD7F

Q39608397-028A5ADE-D2D4-45DC-B3AA-B6905D806071

Q39608397-03EBB6DA-88E6-4BC4-91ED-B1C71F4C72CF

Q39608397-0A591EC1-19A4-449C-985A-6DC9A8FFCEB3

Q39608397-0AB64003-4869-4F2D-A3DD-ACD22CE7B916

Q39608397-0BA1D0B4-DD93-4D71-9383-1A384808634C

Q39608397-0BD99F27-0395-4C2A-A3B8-4431C6FD2929

Q39608397-120DAE32-6262-4175-A409-CBC4194342AD

Q39608397-1879F11E-AE25-4474-899C-36662F5F4378

P304

Q39608397-AE860B42-6DEA-4B33-A716-DE1EA6A4CA97

P31

Q39608397-91EFAAA5-F723-45EE-9369-0CB3E37FA2F4

P356

Q39608397-FD60DD21-4E34-45C0-8776-2B2B22513261

P433

Q39608397-4D993743-5430-44EC-8BDD-892C312880C5

P478

Q39608397-8A58B0FA-EF61-409B-913C-036EE1EB9510

P50

Q39608397-F879024E-A504-428C-90E7-04DA456F1A0E

P577

Q39608397-2B1A7248-16DF-42A5-A08D-E7FFBC4F3DB7

P5875

Q39608397-BC11FDE0-7285-4ECA-BF6A-C9F05C6B42BF

P698

Q39608397-86BD7E85-3518-4DA2-B617-8BD9EF305875

P921

Q39608397-0694DD65-1648-4274-A20C-4AFCDE51D41A

Q39608397-E24BB89E-A4B5-49E1-9AC6-E9995046A356

P932

Q39608397-829B5ECE-68C5-4700-AE43-9AFDD4E94327

P356

P1433

Clinical Lipidology

P1476

Lysophosphatidic acid effects on atherosclerosis and thrombosis.

@en

P2860

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid

Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein

cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases

G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth

Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid

Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex

Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids

Atherosclerosis

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing

P304

413-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CLP.11.38

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51872475

http://www.w3.org/2001/XMLSchema#string

P698

22162980

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3230858

http://www.w3.org/2001/XMLSchema#string